Preliminary study to clarify the mechanism of cancer-related thromboembolism in patients with EGFR mutation positive lung cancer

Preliminary study to clarify the mechanism of cancer-related thromboembolism in patients with EGFR mutation positive lung cancer - Basic research of Rising-VTE

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046863

Enrollment

150

Registered

2022-02-08

Start date

2022-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

EGFR mutation positive non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: EGFR positive non-small cell lung cancer

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Comprehensive measurement of coagulation / fibrinolytic factors in EGFR mutation-positive non-small cell lung cancer	—

Countries

Japan

Contacts

Public ContactKeita Kawakado

Shimane University Hospital Medical Oncology and Respiratory Medicine

keita.kawakado1112@med.shimane-u.ac.jp0853-20-2580

Outcome results